|
National Stock Number(NSN): 6505-01-123-1060 (6505011231060, 011231060)
| NIIN: |
01-123-1060 |
Item Name: |
DOPAMINE HYDROCHLORIDE INJECTION |
INC: |
41749
|
| FSC: |
6505
|
Assignment Date: |
Dec-05-1981 |
CRIT: |
N |
IIG: |
41749 |
| ISC: |
2 |
Date Standardized: |
Nov-18-1987 |
HMIC: |
P |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Jun-01-2003 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-203-8623 |
Item Name: |
DOPAMINE HYDROCHLORIDE AND DEXTROSE INJECTION |
| FSC: |
6505 |
Replacement Date: |
Jun-01-2003 |
|
INC: |
41748 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9093-87 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00015-9093-87 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00074-9105-18 |
70048
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00186-0639-01 |
04473
|
ASTRA PHARMACEUTICALS LP |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
NDC00469-9093-87 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
U |
1 |
A |
$89.96 |
PG |
|
C2201X- |
Feb-01-2002 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$89.96 |
PG |
|
------- |
Mar-01-1998 |
H |
| DM |
S9M |
L |
Z |
M |
U |
1 |
M |
$89.96 |
PG |
|
1-54--- |
Oct-01-2001 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$89.96 |
PG |
|
9L----- |
Mar-01-1998 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$89.96 |
PG |
|
------- |
Mar-01-1998 |
H |
| VA |
JVS |
I |
|
M |
U |
1 |
V |
$0.00 |
PG |
1. |
------- |
Feb-01-1994 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 10EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
40.000 MILLIGRAMS DOPAMINE HYDROCHLORIDE PER MILLILITER |
| CQCT |
PRIMARY CONTAINER TYPE |
SYRINGE-NEEDLE UNIT |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
10.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
DOPAMINE HYDROCHLORIDE INJECTION USP 40MG/ML 10ML UNIT 10S |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
41.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
2.60 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
30 |
| FEAT |
SPECIAL FEATURES |
W/TEN 18 OR 20 GAGE NEEDLE SURROUNDED BY PLASTIC HOOD ALLOWING ONLY 3/8 IN. (0.95 CM) NEEDLE EXPOSURE; FOR USE WITH CARDIOPULMONARY RESUSCITATION KIT,6545-01-079-4253 |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUPP |
SUPPLEMENTARY FEATURES |
D-DAY ITEM FOR DOD |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Nov-08-1993 |
3 |
Z |
|
|
|
|
| FSKX |
|
Nov-08-1993 |
3 |
Z |
|
|
|
|
| MC15 |
|
Oct-15-2001 |
3 |
Z |
|
|
|
|
| N9LM |
|
Nov-08-1993 |
3 |
Z |
|
|
HD |
|
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
Replacement & Obsolete Information
| Obsolete NIIN Information |
|